Semaglutide is a GLP-1 receptor agonist a medication that mimics the naturally occurring GLP-1 hormone your body produces after eating
Small-molecule composition of matter (COM) patents feature a classical generic Markush drawn around examples with the lead clinical candidate(s) at the core
Some people stay here long-term as their maintenance dose and achieve excellent outcomes
Pilon-Thomas S, Kodumudi KN, El-Kenawi AE, Russell S, Weber AM, Luddy K, et al
Following subcutaneous injection, the peptide enters systemic circulation with bioavailability of 14-19% in rats, while intramuscular administration achieves 45-51% bioavailability in beagle dogs, indicating both route-dependent and species-dependent absorption characteristics